Cargando…

The Effect of Food on the Single‐Dose Bioavailability and Tolerability of the Highest Marketed Strength of Duloxetine

Duloxetine is a combined serotonin and norepinephrine reuptake inhibitor indicated in adults for the treatment of major depressive disorder, diabetic peripheral neuropathic pain, and generalized anxiety disorder. The aim of these studies was to evaluate the effect of food on the pharmacokinetics and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rizea‐Savu, Simona, Duna, Simona Nicoleta, Ghita, Adrian, Iordachescu, Adriana, Chirila, Marinela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586977/ https://www.ncbi.nlm.nih.gov/pubmed/31793229 http://dx.doi.org/10.1002/cpdd.759

Ejemplares similares

Single Dose Comparative Bioavailability Study of Lisdexamfetamine Dimesylate as Oral Solution Versus Reference Hard Capsules in Healthy Volunteers
por: Rizea-Savu, Simona, et al.
Publicado: (2022)

Single Dose Study Assessing the Pharmacokinetic and Metabolic Profile of Alverine Citrate in Healthy Volunteers
por: Rizea-Savu, Simona, et al.
Publicado: (2021)

A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine
por: Rodrigues-Amorim, Daniela, et al.
Publicado: (2020)

Does the Excellent Enactment of Highest Strengths Reveal Virtues?
por: Giuliani, Fiorina, et al.
Publicado: (2020)

Near Missed Case of Occupational Pleural Malignant Mesothelioma, a Case Report and Latest Therapeutic Options
por: Handra, Claudia-Mariana, et al.
Publicado: (2022)

The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity
por: Wise, T N, et al.
Publicado: (2007)

Enhancing Bioavailability of Nutraceutically Used Resveratrol and Other Stilbenoids
por: Vesely, Ondrej, et al.
Publicado: (2021)

Duloxetine hydrochloride
por: Bhadbhade, Mohan, et al.
Publicado: (2009)

Duloxetine induced hyponatremia
por: Kulkarni, M.
Publicado: (2015)

Confirmation of diosmetin 3-O-glucuronide as major metabolite of diosmin in humans, using micro-liquid-chromatography–mass spectrometry and ion mobility mass spectrometry
por: Silvestro, Luigi, et al.
Publicado: (2013)

Linkage transitions between oil and the stock markets of countries with the highest COVID-19 cases
por: Hussain, Saiful Izzuan, et al.
Publicado: (2022)

The Effects of Four Compounds That Act on the Dopaminergic and Serotonergic Systems on Working Memory in Animal Studies; A Literature Review
por: Grosu, Ștefania-Alexandra, et al.
Publicado: (2023)

Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder
por: Muscatello, Maria Rosaria Anna, et al.
Publicado: (2019)

Duloxetine for the management of fibromyalgia syndrome
por: Scholz, Beth A, et al.
Publicado: (2009)

Dysosmia and dysgeusia associated with duloxetine
por: Yoshida, Katsuyuki, et al.
Publicado: (2017)

Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
por: Harada, Eiji, et al.
Publicado: (2016)

Baseline depressive symptoms as predictors of efficacy and tolerability of the treatment with duloxetine: a network analysis approach
por: Maciaszek, Julian, et al.
Publicado: (2023)

Challenges in Coopted Hydrophilic and Lipophilic Herbal Bioactives in the Same Nanostructured Carriers for Effective Bioavailability and Anti-Inflammatory Action
por: Iordache, Teodora-Alexandra, et al.
Publicado: (2021)

Too Exhausted to Perform at the Highest Level? On the Importance of Self-control Strength in Educational Settings
por: Englert, Chris, et al.
Publicado: (2017)

Safety, tolerability, pharmacokinetics, pharmacodynamics, bioavailability and food effect of single doses of soticlestat in healthy subjects
por: Wang, Shining, et al.
Publicado: (2021)

Duloxetine in the treatment of stress urinary incontinence
por: Jost, Wolfgang H, et al.
Publicado: (2005)

The role of duloxetine in the treatment of anxiety disorders
por: De Berardis, Domenico, et al.
Publicado: (2008)

Duloxetine in the treatment of generalized anxiety disorder
por: Norman, Trevor R, et al.
Publicado: (2008)

Duloxetine in the treatment of major depressive disorder
por: Goldstein, David J
Publicado: (2007)

Duloxetine in the management of chronic musculoskeletal pain
por: Smith, Howard S, et al.
Publicado: (2012)

Duloxetine in the treatment of generalized anxiety disorder
por: Wright, Alan, et al.
Publicado: (2009)

Structure of racemic duloxetine hydrochloride
por: Bhadbhade, Mohan M., et al.
Publicado: (2023)

Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials
por: Choy, Ernest H. S., et al.
Publicado: (2009)

Efficacy and tolerability of short-term duloxetine treatment in adults with generalized anxiety disorder: A meta-analysis
por: Li, Xinyuan, et al.
Publicado: (2018)

Up to the highest peak!
por: CERN Bulletin
Publicado: (2010)

The Highest Branch of Medicine
Publicado: (1869)

Romanian young adult perceptions on using heated tobacco products following exposure to direct marketing methods
por: Chirila, Sergiu, et al.
Publicado: (2023)

Food and Food Products on the Italian Market for Ketogenic Dietary Treatment of Neurological Diseases
por: Leone, Alessandro, et al.
Publicado: (2019)

The orbitofrontal cortex spontaneously encodes food health and contains more distinct representations for foods highest in tastiness
por: Londerée, Allison M, et al.
Publicado: (2020)

Duloxetine and suicide attempts: a possible relation
por: Salem, Bilal A, et al.
Publicado: (2008)

Duloxetine in the management of diabetic peripheral neuropathic pain
por: Ormseth, Michelle J, et al.
Publicado: (2011)

Update on duloxetine for the management of stress urinary incontinence
por: Basu, Maya, et al.
Publicado: (2009)

Effect of duloxetine in patients with fibromyalgia: tiredness subgroups
por: Bradley, Laurence A, et al.
Publicado: (2010)

Efficacy of Duloxetine in Patients with Chronic Pain Conditions
por: Skljarevski, Vladimir, et al.
Publicado: (2011)

Predictors of duloxetine adherence and persistence in patients with fibromyalgia
por: Cui, Zhanglin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4id53ap9cjbjltt0loei7c29lt